BACKGROUND: Although infections are a major cause of morbidity and mortality after total joint arthroplasty (TJA), little is known about nationwide epidemiology and trends of infections after TJA. QUESTIONS/PURPOSES: We therefore determined (1) trends of postoperative pneumonia, urinary tract infection (UTI), surgical site infection (SSI), sepsis, and severe sepsis after TJA; (2) risk factors of these infections; (3) effect of these infections on length of stay (LOS) and hospital charges; and (4) the infection-related mortality rate and its predictors. METHODS: The International Classification of Diseases, 9th Revision codes were used to identify patients who underwent TJA and were diagnosed with aforementioned infections during hospitalization in the Nationwide Inpatient Sample database from 2002 to 2010. Multivariate analysis was performed to identify risk factors of these infections. RESULTS: Rates of pneumonia, UTI, SSI, sepsis, and severe sepsis were 0.74%, 3.26%, 0.31%, 0.25%, and 0.15%, respectively. Number of comorbidities and type of TJA were independent predictors of infection. Mortality decreased during the study period (odds ratio, 0.87; 95% confidence interval, 0.86-0.89). The median LOS was 3 days without complications but increased in the presence of SSI (median, 7 days), sepsis (median, 12 days), and severe sepsis (median, 15 days). Occurrence of pneumonia, sepsis, and severe sepsis increased risk of mortality 5.2, 8.5, and 66.2 times, respectively. CONCLUSIONS: Rates of UTI, pneumonia, and SSI but not sepsis and severe sepsis are apparently decreasing. The likelihood of infection is increasing with number of comorbidities and revision surgeries. Rate of sepsis-related mortality is also decreasing. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
BACKGROUND: Although infections are a major cause of morbidity and mortality after total joint arthroplasty (TJA), little is known about nationwide epidemiology and trends of infections after TJA. QUESTIONS/PURPOSES: We therefore determined (1) trends of postoperative pneumonia, urinary tract infection (UTI), surgical site infection (SSI), sepsis, and severe sepsis after TJA; (2) risk factors of these infections; (3) effect of these infections on length of stay (LOS) and hospital charges; and (4) the infection-related mortality rate and its predictors. METHODS: The International Classification of Diseases, 9th Revision codes were used to identify patients who underwent TJA and were diagnosed with aforementioned infections during hospitalization in the Nationwide Inpatient Sample database from 2002 to 2010. Multivariate analysis was performed to identify risk factors of these infections. RESULTS: Rates of pneumonia, UTI, SSI, sepsis, and severe sepsis were 0.74%, 3.26%, 0.31%, 0.25%, and 0.15%, respectively. Number of comorbidities and type of TJA were independent predictors of infection. Mortality decreased during the study period (odds ratio, 0.87; 95% confidence interval, 0.86-0.89). The median LOS was 3 days without complications but increased in the presence of SSI (median, 7 days), sepsis (median, 12 days), and severe sepsis (median, 15 days). Occurrence of pneumonia, sepsis, and severe sepsis increased risk of mortality 5.2, 8.5, and 66.2 times, respectively. CONCLUSIONS: Rates of UTI, pneumonia, and SSI but not sepsis and severe sepsis are apparently decreasing. The likelihood of infection is increasing with number of comorbidities and revision surgeries. Rate of sepsis-related mortality is also decreasing. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
Authors: Maureen K Bolon; David Hooper; Kurt B Stevenson; Maurice Greenbaum; Margaret A Olsen; Loreen Herwaldt; Gary A Noskin; Victoria J Fraser; Michael Climo; Yosef Khan; Johanna Vostok; Deborah S Yokoe Journal: Clin Infect Dis Date: 2009-05-01 Impact factor: 9.079
Authors: Luis Pulido; Javad Parvizi; Margaret Macgibeny; Peter F Sharkey; James J Purtill; Richard H Rothman; William J Hozack Journal: J Arthroplasty Date: 2008-09 Impact factor: 4.757
Authors: Kevin J Bozic; Steven M Kurtz; Edmund Lau; Kevin Ong; Vanessa Chiu; Thomas P Vail; Harry E Rubash; Daniel J Berry Journal: Clin Orthop Relat Res Date: 2009-06-25 Impact factor: 4.176
Authors: Daniel D Bohl; Nathaniel T Ondeck; Bryce A Basques; Brett R Levine; Jonathan N Grauer Journal: Clin Orthop Relat Res Date: 2017-12 Impact factor: 4.176
Authors: Lazaros A Poultsides; Georgios K Triantafyllopoulos; Vasileios I Sakellariou; Stavros G Memtsoudis; Thomas P Sculco Journal: Int Orthop Date: 2017-11-12 Impact factor: 3.075
Authors: Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Brent J Morris; David Mannino; Andrew Hoellein; Ryan P Donegan; Leslie J Crofford Journal: Semin Arthritis Rheum Date: 2016-08-24 Impact factor: 5.532
Authors: Mohammad R Rasouli; Jessica Viola; Mitchell G Maltenfort; Alisina Shahi; Javad Parvizi; James C Krieg Journal: Arch Bone Jt Surg Date: 2015-07
Authors: Mariano E Menendez; Stavros G Memtsoudis; Marion Opperer; Friedrich Boettner; Alejandro Gonzalez Della Valle Journal: Int Orthop Date: 2014-08-30 Impact factor: 3.075